Open access
166
Views
15
CrossRef citations to date
0
Altmetric
Original Research
Development and in vitro evaluations of new decitabine nanocarriers for the treatment of acute myeloid leukemia
Thomas Briot1 Micro & Nanomédecines Translationelles – MINT, UNIV Angers, INSERM 1066, CNRS 6021, Université Bretagne Loire, MINT IBS-CHU;2 Pharmacy Department, University Hospital of Angers
, Emilie Roger1 Micro & Nanomédecines Translationelles – MINT, UNIV Angers, INSERM 1066, CNRS 6021, Université Bretagne Loire, MINT IBS-CHU
, Nolwenn Lautram1 Micro & Nanomédecines Translationelles – MINT, UNIV Angers, INSERM 1066, CNRS 6021, Université Bretagne Loire, MINT IBS-CHU
, Alexis Verger1 Micro & Nanomédecines Translationelles – MINT, UNIV Angers, INSERM 1066, CNRS 6021, Université Bretagne Loire, MINT IBS-CHU
, Anne Clavreul3 Neurosurgery Department, University Hospital of Angers;4 CRCINA, INSERM, Université de Nantes, Université d’Angers, Angers, France
& Frederic Lagarce1 Micro & Nanomédecines Translationelles – MINT, UNIV Angers, INSERM 1066, CNRS 6021, Université Bretagne Loire, MINT IBS-CHU;2 Pharmacy Department, University Hospital of AngersCorrespondence[email protected]
Pages 8427-8442
|
Published online: 23 Nov 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.